MODERATOR Ira M. Jacobson, MD Chief of the Division of Gastroenterology and Hepatology Professor of Medicine Weill Cornell Medical College New York, New York
PRESENTERS Su Wang, MD, MPH Assistant Director of Medical Affairs Charles B. Wang Community Health Center New York, New York
Brian R. Edlin, MD Professor of Medicine SUNY Downstate College of Medicine Attending Physician, University Hospital of Brooklyn Brooklyn, New York Adjunct Associate Professor of Medicine Weill Cornell Medical College Attending Physician, New York-Presbyterian Hospital New York, New York
Vernon K. Smith, PhD Principal Health Management Associates Lansing, Michigan
Edward A. Chow, MD Chief Medical Officer Chinese Community Health Plan Member, San Francisco Health Commission San Francisco, California
DISCLOSURES
Dr Jacobson reports the following: Consultant: Abbott, Anadys, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences Inc., Globelmmune, Inc, Human Genome Sciences, Idenix, Intermune, Merck, Novartis, Pfizer, Pharmasset, Progenics, Roche Pharmaceuticals, Sanofi-Aventis, Schering-Plough, Tibotec, Vertex Pharmaceuticals, Virochem, Zymogenetics. Grant/Research Support Anadys, Boehringer Ingelheim, Gilead Sciences Inc., Globelmmune, Inc, Human Genome Sciences, Idenix, Intarcia, Merck, Novartis, Pharmasset, Roche Pharmaceuticals, Romark, Schering-Plough, Tibotec, Valeant, Vertex Pharmaceuticals. Speakers Bureau: Bristol-Myers Squibb, Gilead Sciences Inc., Novartis, Schering-Plough
Dr Wang, Dr Edlin, Dr Smith, and Dr Chow have no real or apparent conflicts of interest to report.
